“Sonja.b Biotech”, a leading name in Healthcare, offers wide range of formulations from tablets to injectables, from capsules to newer drugs. It is a indian pharmaceutical company providing high quality, affordable medicines trusted by healthcare professionals and patients across country. Our presence extends across therapies and spans Anti-infectives, Cardiovascular, Pain management, Central Nervous System (CNS), Gastrointestinal, Respiratory, Dermatology, Orthopaedics, Nutritionals and Urology.
The belief that quality healthcare services have no boundaries in a global world drives, we to deliver the best healthcare products in its markets. A ‘People-First Policy’ ensures that we meets and surpasses the evolving expectations of its customers, at all times.
Since inception, we are a quality-focused organization. We ensure that only the finest quality products are offered to our clients at market leading rates. We source our range from trusted and well-established market vendors, who have proved their expertise in the market. After the procurement is made, our products are thoroughly checked and are put through a series of quality checks. Owing to efficient quality control, we are able to offer accurate composed products in the market.
Sonja.b Biotech is a business operating as a strategic outsourcing partner to the pharmaceutical industry for pharmaceutical development, commercial manufacturing of medicinal products (including the manufacture of investigational medicinal products for clinical trials), contract packaging and logistics services.
It is the policy of Sonja.b Biotech to ensure that all products and services offered to our company’s customers consistently conform to all applicable regulatory requirements and with the principles and guidelines of current Good Manufacturing Practice (cGMP) to ensure a “fitness for use” expected by our customers’ contractual expectations.
Furthermore, it is our policy to ensure that (1) Sonja.b Biotech facilities and (2) product development, manufacturing and logistics processes that directly affect the quality of the final medicinal product, are identified and controlled to provide a high degree of assurance that each commercial product consistently meets its pre-defined specifications and quality attributes.
Sonja.b Biotech conducts its business in accordance with the relevant global regulatory requirements, including European Directives 2001/83/EC and 2003/94/EC, code of federal regulations parts 210 and 211 and other global territory regulatory guidance.